| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/24/2007 | CA2243708C Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/24/2007 | CA2234610C New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 04/24/2007 | CA2206593C Centrifuge with annular filter |
| 04/24/2007 | CA2188654C Modified milk growth factor |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2141951C Inhibition of retrovirus infection |
| 04/24/2007 | CA2136441C Adeno-associated virus with inverted terminal repeat sequences as promoter |
| 04/24/2007 | CA2106827C Pharmaceutical compositions containing cyclosporins |
| 04/24/2007 | CA2091346C Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/24/2007 | CA2073855C Glycoalkaloids for controlling cellular autophagy |
| 04/20/2007 | CA2562249A1 Anf analogue |
| 04/19/2007 | WO2007044998A1 Retrocyclins: antiviral and antimicrobial peptides |
| 04/19/2007 | WO2007044989A2 Modulators of nod1 signaling |
| 04/19/2007 | WO2007044906A2 Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides |
| 04/19/2007 | WO2007044874A2 Use of factor vii polypeptides for neuroprotection |
| 04/19/2007 | WO2007044758A2 Anti-neoplastic agent combination therapy and method of administration thereof |
| 04/19/2007 | WO2007044745A1 Lantibiotic and mupirocin compositions for treating bacterial infections |
| 04/19/2007 | WO2007044700A2 Protectant combinations for reducing toxicities |
| 04/19/2007 | WO2007044639A2 Novel delivery of immune response modifiers for removal of chronic tattoos |
| 04/19/2007 | WO2007044591A2 Vasoactive intestinal polypeptide pharmaceuticals |
| 04/19/2007 | WO2007044534A2 Vegf analogs and methods of use |
| 04/19/2007 | WO2007044522A1 P62 as a risk determinant for metabolic syndrome |
| 04/19/2007 | WO2007044476A2 Lysozyme fortified milk and milk products |
| 04/19/2007 | WO2007044375A2 Pth formulations and methods of use |
| 04/19/2007 | WO2007044362A2 Allele-specific rna interference |
| 04/19/2007 | WO2007044323A2 Fusion proteins for blood-brain barrier delivery |
| 04/19/2007 | WO2007044069A2 Pth formulations and methods of use |
| 04/19/2007 | WO2007044059A2 Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
| 04/19/2007 | WO2007044026A2 Compositions comprising modified collagen and uses therefore |
| 04/19/2007 | WO2007043900A1 Use of lactoferrin fragments and hydrolysates |
| 04/19/2007 | WO2007043870A1 Leucine rich composition |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043640A1 Substance for use in treatment or prevention of hcv infection |
| 04/19/2007 | WO2007043630A1 Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane |
| 04/19/2007 | WO2007043629A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | WO2007043606A1 Antidiabetic agent comprising anionic polyamino acid-metal complex |
| 04/19/2007 | WO2007042792A1 Gpr 146 receptor |
| 04/19/2007 | WO2007042602A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/19/2007 | WO2007042524A2 Treating diabetes using inhibitors of il-1 |
| 04/19/2007 | WO2007042254A1 C-krox peptides and analogs thereof for treating skin ageing |
| 04/19/2007 | WO2007042037A1 Tacrolimus combination products |
| 04/19/2007 | WO2007042010A2 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 04/19/2007 | WO2007041964A1 The use of long half-life human recombinant soluble tumor necrosis factor alpha receptor in preparing the medicine which can prevent hepatic failure |
| 04/19/2007 | WO2007041833A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 04/19/2007 | WO2007041832A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | WO2007041773A1 Sumoylation control agent and uses thereof |
| 04/19/2007 | WO2007025249A3 Methods for treatment of headaches by administration of oxytocin |
| 04/19/2007 | WO2007022635A3 Methods of attenuating prostate tumor growth by insulin-like growth factor binding protein-3 (igfbp-3) |
| 04/19/2007 | WO2007016364A3 Peptide deformylase inhibitors |
| 04/19/2007 | WO2007015069A3 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 04/19/2007 | WO2007010401A3 Glycosylated il-7, preparation and uses |
| 04/19/2007 | WO2007009233A3 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases |
| 04/19/2007 | WO2007009062A3 Treatment of leg ulcers using placenta derived collagen biofabric |
| 04/19/2007 | WO2007009012A3 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/19/2007 | WO2007005320A3 Methods of delivering corticotroph-derived glycoprotein hormone |
| 04/19/2007 | WO2006136419A3 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| 04/19/2007 | WO2006134195A3 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 04/19/2007 | WO2006130580A3 Mutant il-10 |
| 04/19/2007 | WO2006123354B1 Oral pharmaceutical composition |
| 04/19/2007 | WO2006114448A3 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 04/19/2007 | WO2006113841A3 Nucleic acid-like proteins |
| 04/19/2007 | WO2006097432A3 Keratin-binding desmoplakin polypeptide sequences |
| 04/19/2007 | WO2006091775A3 Tropoelastin for promoting endothelial cell adhesion or migration |
| 04/19/2007 | WO2006088972A3 Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism |
| 04/19/2007 | WO2006088925A3 Use of il17-f in diagnosis and therapy of airway inflammation |
| 04/19/2007 | WO2006076678A3 Prostate stem cell antigen vaccines and uses thereof |
| 04/19/2007 | WO2006055532A3 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 04/19/2007 | WO2006017913A9 Peptide inhibitors of c-jun dimerization and uses thereof |
| 04/19/2007 | WO2006015882A3 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 04/19/2007 | WO2006015275A8 Method for enhancing bone formation |
| 04/19/2007 | WO2005081619A3 Compounds and methods for increasing neurogenesis |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2005021578A3 A novel chimeric polypeptide and use thereof |
| 04/19/2007 | WO2004091475A3 Gaucher disease drugs and methods of identifying same |
| 04/19/2007 | WO2004080392A3 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 04/19/2007 | WO2004058189A3 Chemokine antagonists and uses thereof |
| 04/19/2007 | US20070089176 Cytokine involved in epithelial-mesenchymal transition |
| 04/19/2007 | US20070088151 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/19/2007 | US20070088045 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 04/19/2007 | US20070088017 Benzothiazole derivatives for the treatment of diabetes |
| 04/19/2007 | US20070087992 Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof |
| 04/19/2007 | US20070087991 Pluripotential stem cells |
| 04/19/2007 | US20070087990 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 04/19/2007 | US20070087989 siRNA specific for myocilin and mutant myocilin; double stranded RNA; gene expression inhibition; for treatment of glaucoma |
| 04/19/2007 | US20070087986 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 04/19/2007 | US20070087974 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 04/19/2007 | US20070087973 producing (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide, used as serine protease inhibitors, useful for treatment of hepatitis C virus infections |
| 04/19/2007 | US20070087972 Prion-specific peptoid reagents |
| 04/19/2007 | US20070087971 Peptides, derivatives and analogs thereof, and methods of using same |
| 04/19/2007 | US20070087970 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 04/19/2007 | US20070087969 Wound healing and treatment of fibrosis |
| 04/19/2007 | US20070087968 Methods to treat T-cell disorders using TISF |
| 04/19/2007 | US20070087967 Methods and compositions for inhibiting angiogenesis |
| 04/19/2007 | US20070087966 Using polypeptide which comprises a prolactin molecule, or a variant thereof for therapy of pain |
| 04/19/2007 | US20070087965 Treatment of psoriasis through down-regulation of the egf-receptor with topically applied egf |
| 04/19/2007 | US20070087964 Novel compositions and methods for modulating the acid-sensing ion channel (asic) |
| 04/19/2007 | US20070087963 Synthesis of cyclosporin analogs |
| 04/19/2007 | US20070087962 Pharmaceutical compositions comprising cyclosporins |
| 04/19/2007 | US20070087961 Conjugates of hydroxyalkyl starch and erythropoietin |